Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: a report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators.
Dzavik V, Ghali WA, Norris C, Mitchell LB, Koshal A, Saunders LD, Galbraith PD, Hui W, Faris P, Knudtson ML; Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Dzavik V, et al. Am Heart J. 2001 Jul;142(1):119-26. doi: 10.1067/mhj.2001.116072. Am Heart J. 2001. PMID: 11431667 Clinical Trial.
An open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting, with a heparin-coated stent, of totally occluded coronary arteries: rationale, trial design and baseline patient characteristics. Total Occlusion Study of Canada (TOSCA) Investigators.
Dzavik V, Carere RG, Teo KK, Knudtson ML, Marquis JF, Buller CE. Dzavik V, et al. Can J Cardiol. 1998 Jun;14(6):825-32. Can J Cardiol. 1998. PMID: 9676168 Review.
Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA).
Dzavik V, Carere RG, Mancini GB, Cohen EA, Catellier D, Anderson TE, Barbeau G, Lazzam C, Title LM, Berger PB, Labinaz M, Teo KK, Buller CE; Total Occlusion Study of Canada Investigators. Dzavik V, et al. Am Heart J. 2001 Aug;142(2):301-8. doi: 10.1067/mhj.2001.116960. Am Heart J. 2001. PMID: 11479470 Clinical Trial.
Effect of serum lipid concentrations on restenosis after successful de novo percutaneous transluminal coronary angioplasty in patients with total cholesterol 160 to 240 mg/dl and triglycerides < 350 mg/dl.
Dzavik V, Teo KK, Yokoyama S, Modi R, Dinwoodie A, Burton JR, Tymchak WJ, Montague TJ. Dzavik V, et al. Am J Cardiol. 1995 May 1;75(14):936-8. doi: 10.1016/s0002-9149(99)80691-2. Am J Cardiol. 1995. PMID: 7733005 Clinical Trial. No abstract available.
Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial.
Webb JG, Lowe AM, Sanborn TA, White HD, Sleeper LA, Carere RG, Buller CE, Wong SC, Boland J, Dzavik V, Porway M, Pate G, Bergman G, Hochman JS; SHOCK Investigators. Webb JG, et al. Among authors: dzavik v. J Am Coll Cardiol. 2003 Oct 15;42(8):1380-6. doi: 10.1016/s0735-1097(03)01050-7. J Am Coll Cardiol. 2003. PMID: 14563578 Free article. Clinical Trial.
Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]--a pilot study).
Dzavik V, Beanlands DS, Davies RF, Leddy D, Marquis JF, Teo KK, Ruddy TD, Burton JR, Humen DP. Dzavik V, et al. Am J Cardiol. 1994 May 1;73(12):856-61. doi: 10.1016/0002-9149(94)90809-5. Am J Cardiol. 1994. PMID: 8184807 Clinical Trial.
279 results